LXRX icon

Lexicon Pharmaceuticals
LXRX

Overview Fund Activity

121 hedge funds and large institutions have $582M invested in Lexicon Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
-1
Holders Change %
-0.82%
% of All Funds
2.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
38
Reduced
32
Closed
18
Calls
$1.36M
Puts
$5.14M
Net Calls
-$3.78M
Net Calls Change
-$1.98M

Top Buyers

1
First Manhattan
1
First Manhattan
New York
$15.3M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$21.8M
3
Macquarie Group
3
Macquarie Group
Australia
$2.5M
4
Bank of America
4
Bank of America
North Carolina
$2.06M
5
PAMU
5
Pictet Asset Management (UK)
United Kingdom
$3.26M

Top Sellers

1
UBS AM
1
UBS AM
Illinois
$6.2M
2
State Street
2
State Street
Massachusetts
$5.18M
3
CS
3
Candriam SCA
Luxembourg
$0
4
SGA
4
Sector Gamma AS
Norway
$2.09M
5
TRSOTSOK
5
Teachers Retirement System of the State of Kentucky
Kentucky
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Lazard Asset Management
126
Lazard Asset Management
New York
– -$300K -45,200 Closed
WCM
127
Weld Capital Management
New York
– -$150K -22,549 Closed
Man Group
128
Man Group
United Kingdom
– -$136K -20,500 Closed
QIM
129
Quantitative Investment Management
Virginia
– -$112K -16,900 Closed
II
130
Inspire Investing
Idaho
– -$87K -13,059 Closed
TI
131
Trexquant Investment
Connecticut
– -$67K -10,117 Closed
Group One Trading
132
Group One Trading
Illinois
– -$18K -2,785 Closed
Bank of Montreal
133
Bank of Montreal
Ontario, Canada
– -$4K -605 Closed
PHK
134
Point72 Hong Kong
Hong Kong
– -$2K -274 Closed
2 3 4 5
6